WCN26-7163 Disease activity assessed by glomerular Gd-IgA1 deposition

Read full text Summarise with VIRAT
Authors: Mai Akimoto, Kazuaki Mori, Ryousuke Aoki, Nozomi Kadota, Yukako Umezawa, Tomoyuki Otsuka, Maiko Nakayama, Masahiro Muto, Hisatsugu Takahara, Shigeki Tomita, Yusuke Suzuki, Hitoshi Suzuki
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis. While there is a high risk of progression to end-stage kidney disease within their lifetimes, outcomes vary widely. Galactose-deficient IgA1 (Gd-IgA1) has a key role in the pathogenesis of IgAN, and Gd-IgA1 specifically deposit in the glomeruli in patients with IgAN. Although the indication of immunosuppressive therapy should be determined based on histological and clinical severity, immunosuppressive therapy allows some patients to reach complete remission (CR) of urinary abnormalities and maintain renal function.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Vasculitis and related conditions Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106288–106288
Publication date
25 March 2026
Language
EN